Denial - Yes, mentioned:
"Preferably, the mammal is suffering from an arthritic condition. The arthritic condition is preferably selected from rheumatoid arthritis or osteoarthritis. Preferably, the arthritic condition is rheumatoid arthritis. Preferably, the arthritic condition is osteoarthritis. Preferably, the osteoarthritis is in an articulating joint selected from the group consisting of: an ankle, a hip, knee, shoulder, spine and wrist. The osteoarthritis is preferably in the knee. Preferably, the osteoarthritis is in the spine (spondylosis)."
..and further (in a few places in the doc) ...
" The use according to example embodiment 31, wherein the osteoarthritis is in the spine (spondylosis). "
Ref: https://patentscope.wipo.int/search/en/detail.jsf?docId=AU368914118&_cid=P21-LJ5LNR-53391-22
- Forums
- ASX - By Stock
- PAR
- Resolution of lumbar bone marrow oedema
Resolution of lumbar bone marrow oedema, page-74
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.73M |
Open | High | Low | Value | Volume |
23.0¢ | 23.0¢ | 21.5¢ | $78.13K | 350.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 64880 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 43479 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 64880 | 0.220 |
12 | 212910 | 0.215 |
14 | 245866 | 0.210 |
8 | 182478 | 0.205 |
30 | 784855 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 43479 | 1 |
0.230 | 84999 | 2 |
0.235 | 26540 | 1 |
0.240 | 103500 | 4 |
0.250 | 109857 | 5 |
Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online